The goal of this activity is for learners to be better able to examine the scientific rationale for pharmacogenetic (PGx) testing in depression medication selection, translate the latest clinical evidence for PGx testing, and incorporate PGx testing into the clinical management of patients with MDD.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1000459
- Start Date: 2024-04-17 05:00:00
- End Date: 2024-04-17 05:00:00
- Credit Details: IPCE Credits: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABIM - 0.75 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Myriad (Any division) - Amount: 70698.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine
Subscribe
Login
0 Comments
Oldest